1 Cooper C,Campion G,Melton LJ.Hip tractures in the elderly a world wide projection.Osteoporosis INt,1992;2:285
2 Fastell R.Treatment of postmenopausal osteo -porosis.New Eng J Med,1998;338:736
3 Parfitt AM,Mundy GR,Roodman GD,et al.A new model for the regulation of bone resorption,with particular reference to the effects of bisphos-phonates.J Bone Miner Res,1996;11:150
4 Lindsay R,Mckhart D,Krasewski A.A prospec -tive double blind trial of Synthetic steroid (Org OD14 )for prev enting postm enopausal osteoporosis.BMJ,19802:1207
5 Rymer J,Chapman M G,Fogelman I.Effect of tiboloneon postme no pausal bone loss.Osteoporosis Int,1994;4:314
6 Guesens P Dequeker J,Gielen J,et al.Nontinear increase in vertebral density induced by a synthetic steroid(Org OD14) in women with established osteoporosis,Maturitas,1991;13:155
7 Studd J,Arnala I,Zamblera D,et al.Tibolone increases bone mass in women with prvious frac-tures in a placebo cont rolleed bicentre study.Osteoporosis In t,1996;6(supple1):231
8 Grey A,Cundy T,Evans M,et al.M edroxy pro-gesterone acetate enhances the Spinal bonemineral density reponse to oestrogen inlate.post me nopausal women.Clin Endocrinol,1996;44:293.
9 Grey A,Cundy TF,Reid IR.Continuous om -bined oest rogen progestin therapy is well tolerated and increases bone density at the hip and spine in post me nopausal osteoporosis.Clin E ndocrinol,199440:671
10 HughesDE,Wright KR,Uy HL.Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo.J Bone Miner Res,1995;10:1478
11 Patel S.Current and potential future drug treat -ment for osteoporsis.Ann Rheum Dis,1996;55:700
12 Storm T,Thamsborg G,Steinich T,et al.Effect of intermit tent cyclical etidronate therapy onbonemass and fracture rate in women with post-menopausalosteoporosis.N Engl J Med,1990;322:1265
13 Watts NB,Harris ST,Genant H K.Intermittent Cyclical etidronate treatment of postmenopausal osteoporosis.N Engl J Med,1990;323:73
14 Chesnut CH,Mc Clung MR,Ensrud KI:Alendronate treatment of the postme no pausal osteoporotic woman effect of multple dosages on bone mass and bone remodeling Am J Med,1995;99:144
15 M ort tensen L,Bekker P,vander Ouweland F.Prevention of early postmenopausal bone loss by risedronatea two year study.J Bone Miner Res,1995;10S140
16 Filipponi P,Pedetti M,Fedeli L.Cyelical ntra-ve nous clodronate in postmenopausal osteoporosis:resultsof a long term clinical trial.Bone,1996;18:1:79
17 ReidIR,Wattie DJ.Evans MC,et al.Continuous therapy with pamidronate,a potent bisphospho -nate,in postme no pausal osteoporosis.J Clin En -docrinol M eltabol,1994;9:1595
18 OvegaardK,Ris B.Nasal calcionins and osteo-pomsis.Calkif Tiss Int1994;55:79
19 DawsonHughes B,Dallal GE,Krall EA,et al.Aontolled trial of the efect of akciun supple -mentation on bone density in podm enopausal women.N EnglJ Med,1990;323:878
20 Lane JM,Scaduto AA.Recent adwances in drug therapy for osteoporosis.Curr opin Ortbop,1995;6:1
21 Riggs BL.Formation stimulating regimens other than sodium fluoride.Am J Med,199395:62
22 Bonueei E,Ballanti P,M areli A,et al.Iprilavone inhibits osteoclast differentiation in pa rathy roid transplanted parietal bone of rats.Caleif Tis Int,1992;50:314
23 Tumer GH.Toward a cure foroste Oporosis reversal ofexoessive bone fragility.Osteporosis Int,1991;2:12
24 Rudman D.Feller AG,Nagraj HS,et al Effects of human growth hormone in menover60 years old.N Engl J Med,1990;232:1
25 HodmanAB,Fraher LJ,Waton PH.A random ixed controlled trial to compare the efficacy of cyelical pura thy roid horm one versus gelical arahy -roid homone and equential akcitonin to imp rove bone mass in postmenopausal women with osteo porosis,J Clin Endocrinol M elab,1997;82:620
26 Lindsay R,Nieves J,Formica C.Randomised ontrolled study of effect of parathy roid hormone on vertebral bone mass and fraclu re incidence am ong postmenopausal W omen on oestrogen with osteoporoeis.Lanocet,1997;350:550
27 Brown EM,Gamba G,Riccardi D,et al.Cloning and characterisalon of an extracellular Ca2+ensing receptor from bovine parathyroid.Nalure,1999;366:575
28 Tsurukami H,Nakamun T,Suzuki K,et al.A nmovel synthetic vi tamin D analogue,2 beta (3 -hy -droxypropoxy )1 alpha,25 dihydroxyvitamin D3( ED71) inereases bone mass by stiulating the bone formation innormal and ovariectomized rals.Caleifiss Int,199454:142
29 Keeting PE,Oursler MJ,Wiegand KE,et al.Zeolite A increases prolife ration differentiation and transforming rowth factor beta in normal adult human ostobasttike cells in vitro.J Bone Miner Res,1992;7:1281
30 Brandi ML:New trealmentst ralegies ipriflavone,strontium,vitamin D me labolites and analogs.Am J Med,1993;95:69 |
